Table 1 Clinical and nutritional characteristics of the participants (n = 441).
Characteristics | |||
|---|---|---|---|
Age (years) | |||
Median [range] | 76.0 | [70–96] | |
IQR [Q1–Q3] | [73.0-80.0] | ||
Sexa | |||
Male | 216 | 49.0% | |
Female | 225 | 51.0% | |
Reasons for the first hospitalization | |||
Chemotherapy | 182 | 41.3% | |
Radiotherapy | 74 | 16.8% | |
Others (e.g., targeted therapy) | 185 | 41.9% | |
Metastatic Diseasea | 319 | 72.3% | |
Primary cancer locationa | |||
Gastrointestinal tract | 133 | 30.9% | |
Urological tract | 89 | 20.7% | |
Breast | 64 | 14.9% | |
Lung | 30 | 7.0% | |
Head and Neck | 22 | 5.1% | |
Gynaecologist | 31 | 7.2% | |
Others | 61 | 14.2% | |
ECOG-Performance statusa | |||
0–1 | 192 | 43.5% | |
2 | 141 | 32.0% | |
3–4 | 108 | 24.5% | |
Current weight (kg) | |||
Median [range] | 65.0 | [33-135] | |
IQR [Q1–Q3] | [55–75] | ||
Weight loss compared with usuala,b | |||
<5% | 140 | 31.7% | |
≥5% | 301 | 68.3% | |
C-Reactive Protein concentration (mg/L) | |||
Median [range] | 29.8 | [0-393] | |
IQR [Q1–Q3] | [7.0-77.6] | ||
C-Reactive Protein concentrationa | |||
<2 mg/L | 29 | 9.4% | |
[2–10[mg/L] | 66 | 21.5% | |
[10–100[mg/L | 161 | 52.4% | |
>100 mg/L | 51 | 16.6% | |
Missing | 134 | ||
Body mass indexa | |||
≤22 | 153 | 34.9% | |
>22 | 286 | 65.1% | |
Missing | 2 | ||
MNA-SF scorea | |||
0–7 | 204 | 50.1% | |
8–11 | 174 | 42.8% | |
12–14 | 29 | 7.1% | |
Missing | 34 | ||
Ingesta-VAS scorea | |||
≤7 | 290 | 65.8% | |
>7 | 151 | 34.2% | |
Median [range] | 6 | [1–10] | |
IQR [Q1–Q3] | [4–8] | ||
Energy intake (kcal/kg/day-) | |||
Median [range] | 19.1 | [1.4-48.9] | |
IQR [Q1–Q3] | [13.7-25.0] | ||
Energy intakea | |||
<25 kcal/kg/day | 328 | 74.4% | |
≥25 kcal/kg/day | 113 | 25.6% | |